Company intelligence / Profile preview

SocraTec R&D

Oberursel, Germany

Ownership: Private
Employees: ~75
Development stage: Other

Overview

SocraTec R&D has conducted several hundred Phase I trials—including first-in-human and vaccination studies—as well as bioavailability and bioequivalence studies for various dosage forms. The company manages clinical research from early phase to late-stage efficacy trials for pharmaceutical and biotechnology clients[1][2][3].

Therapeutic areas: GastroenterologyPulmonologyCardiovascularMen's HealthNephrologyOphthalmologyOtherWomen's HealthOncologyNeurology
Modalities: Small moleculeBiologic
Industry: Contract Research Organization

Partnerships

August Research (for multicenter/multinational clinical trials Europe-wide and US)

Beyond the preview

Go deeper on SocraTec R&D.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SocraTec R&D.

Explore the full profile